Learn About New Therapies for Type 2 Diabetes

OSUWexnerbloglogo2014 Learn About New Therapies for Type 2 Diabetes. 25 years ago, the management of type II diabetes was easy. You started a patient on a sulfonylurea and then if their glucose level didn’t improve, you added in NPH insulin. But things have changed. And today, we have better and safer medications to treat diabetes. Which is a good thing because the prevalence of diabetes over the past 25 years has grown enormously and we really needed new treatments to fight against this public health threat. But with new treatments can come confusion about which to use in different clinical situations. Joining our moderator on this CME webcast, to update us on the management of type 2 diabetes is endocrinologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Joshua Joseph.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DESCRIBE the role of new medical therapies in hypoglycemia; and DESCRIBE the role of new medical therapies in cardiovascular disease.

You’ll also learn about the following:

  • New directions in the treatment of type 2 diabetes
  • Hemoglobin A1C targets
  • Treatment of type 2 diabetes when medication cost is a consideration
  • New glucose monitoring technologies

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Accountable Care Organizations

OSUWexnerbloglogo2014 Learn about Accountable Care Organizations during our CME webcast. As of August 2017, there are 480 shared saving program ACOs covering 9 million Medicare beneficiaries. That is 1 out of every 5 people on Medicare today. On this CME webcast, we are going to introduce you to the Accountable Care Organization: why they exist, how they work, and whether you should participate in one. Joining our moderator in the studio are ACO experts from the Ohio State University. Dr. Randy Wexler is an Associate Professor and the Vice Chair of Clinical Affairs in the Department of Family Medicine. Also, we have Dr. Gail Grever who is an Assistant Professor of Internal Medicine in the Division of General Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: better UNDERSTAND the cost reasons behind value based health care; UNDERSTAND the variations of value based reimbursement; DISCUSS elements necessary for success of an ACO; and better UNDERSTAND definition of Accountable Care Organizations.

You’ll also learn about the following:

  • HMOs versus ACOs
  • When should you expect to get an end of the year shared savings bonus
  • How baseline patient population characteristics affect the probability of an ACO’s success
  • Characteristics of a successful ACO structure
  • The role of the electronic medical record in an ACO
  • ACOs and commercial insurance companies
  • How are patients assigned to an ACO
  • Whether being in an ACO restricts a patient’s choice of doctors?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.